Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: BNT162B2 (COMIRNATY), intravenous; Acute myocardial infarction; This is a spontaneous report received from a non-contactable consumer via regulatory authority (PEI) and downloaded from the Medicines Agency (EMA) EudraVigilance-WEB DE-PEI-CADR2021016955. A 47-year-old female patient received BNT162B2 (COMIRNATY, lot number unknown), intravenous on 07Feb2021 at single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 08Feb2021 the patient experienced acute myocardial infarction reported as serious death. The patient died on 08Feb2021. It was unknown if autopsy was performed and the reported cause of death was acute myocardial infarction. The outcome of the event was fatal. Causality from PEI: Inconsistent causal association to immunization. Sender Comment: death No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Acute myocardial infarction
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166